Kashiwagi S
Hokkaido Igaku Zasshi. 1986 Jul;61(4):533-45.
I have examined Ferrokinetics and the activity of serum erythropoietin (by Frieds method) for determining the in vivo erythropoiesis, additionally the presence of "effective" or "ineffective" erythropoiesis in patients with hypoplastic anemia. The number of reticulocytes and the reticulocyte production index also were analysed concerning erythropoiesis. Based on above-mentioned findings, the prognosis of these patients was analysed. Furthermore, from the relationship between the morphological examination of the erythroid cells in the bone marrow and the time course of the activity of serum erythropoietin, the change of erythropoiesis was investigated. From these results, a higher level of serum erythropoietin was observed in patients with more severe type in erythropoiesis, whereas the prognosis in these patients was much poorer in relation to an elevated value of serum erythropoietin. Furthermore, it might be suggested that a high level of erythropoietin which is enough to help the erythroid progenitor cells to differentiate and maturate to normal erythroblasts was able to shorter the maturation time of the erythroid cells and also effectively abolished "ineffective erythropoiesis" inducing the proper erythropoiesis.
我已检测铁动力学和血清促红细胞生成素活性(采用弗里兹法)以测定体内红细胞生成情况,此外还检测了再生障碍性贫血患者中“有效”或“无效”红细胞生成的存在情况。还分析了网织红细胞数量和网织红细胞生成指数与红细胞生成的关系。基于上述发现,对这些患者的预后进行了分析。此外,从骨髓中红系细胞的形态学检查与血清促红细胞生成素活性的时间进程之间的关系,对红细胞生成的变化进行了研究。从这些结果可以看出,红细胞生成更严重类型的患者血清促红细胞生成素水平较高,而这些患者的预后与血清促红细胞生成素升高值相关则更差。此外,可能表明足以帮助红系祖细胞分化并成熟为正常成红细胞的高水平促红细胞生成素能够缩短红系细胞的成熟时间,并且还能有效消除“无效红细胞生成”,诱导正常的红细胞生成。